 Phase: Phase IIType: TreatmentStatus: CompletedAge: 18 and overSponsor: Pharmaceutical IndustryProtocol IDs: CP14B013, NCT01242930Phase: Phase IIType: TreatmentStatus: ClosedAge: 12 months to 21 yearsSponsor: NCI, OtherProtocol IDs: PBTC-036, NCI-2013-00482, U01CA081457, NCT01836549 